FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:892 September 21, 2000 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

(Advances in Blood Disorders. Vol. 5.) Edited by Martin S. Tallman and Aaron Polliack. 189 pp., illustrated. Amsterdam, Harwood Academic, 2000. $65. ISBN 90-5823-009-0.

Hairy-cell leukemia has been the subject of more scientific reports than its rarity might warrant. Many early studies dealt with the morphologic characteristics of hairy cells, the pathological features of involved tissues, tartrate-resistant acid phosphatase as a marker, the cellular lineage of hairy cells, the clinical response to splenectomy, and the dramatic results of treatment with interferon, pentostatin, and cladribine. We now know that cells with "hairs" may not be hairy cells. This cytologic feature may prevail in phorbol ester–stimulated chronic lymphocytic leukemia cells and in splenic lymphoma with villous lymphocytes.

Variants of hairy-cell leukemia include the blastic subtype, the . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.